 |
Medscape Conference Coverage, based on selected sessions at the: 55th Annual Meeting of the American Association for the Study of Liver Diseases October 29, 2004 - November 2, 2004, Boston, Massachusetts
This activity is not sanctioned by, nor a part of, the American Association for the Study of Liver Diseases.
|
| Topic Overviews | |
| Viral Liver Disease CMEPhysicians - up to 1.25 hour(s) of AMA PRA category 1 credit| • | Developments in the Management of
Hepatitis B
Daniel S. Pratt, MD | | • | Hepatitis C -- Current State of the Art and Future Directions
David Bernstein, MD | | • | Coinfection With HIV and Hepatitis C or Hepatitis B
Adrian M. Di Bisceglie, MD, FACP |
Cirrhosis and Its Complications CMEPhysicians - up to 1.25 hour(s) of AMA PRA category 1 credit| • | Liver Transplantation -- New Developments
Tram T. Tran, MD | | • | Management of Decompensated Cirrhosis
Steven K. Herrine, MD | | • | Clinical Developments in Hepatocellular Carcinoma
Alex S. Befeler, MD |
Nonviral Liver Disease CMEPhysicians - up to 0.75 hour(s) of AMA PRA category 1 credit| • | Alcohol-Induced Liver Injury
Willis C. Maddrey, MD | | • | Genetic and Metabolic Influences, Including Obesity, on Liver Disease
William F. Balistreri, MD |
|
| | | Daily Commentary and Expert Interview | |
|
| Conference News | |
|
| Legal Disclaimer | |
| The materials presented here were prepared by independent authors under the editorial supervision of Medscape, and do not represent a publication of the American Association for the Study of Liver Diseases. These materials and the related activity are not sanctioned by the American Association for the Study of Liver Diseases or Gilead, and do not constitute an official part of the AASLD conference. The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2004 Medscape. |
|
|
|
